LOX and laryngotracheoesophageal cleft: Nevertheless, the result of this analysis added new evidence that LOXL3 could be potentially used a prognostic biomarker in addition to LOX. A nomogram based on LOX, LOXL3, and other predictors were developed which can help predict the mortality risk for an individual LC patient.